Merck & Co., Inc. (NYSE:MRK)

stock symbol ticker

The 4 Stocks That Boosted the Dow on Tuesday

April 28, 2015: Markets opened slightly higher on Tuesday but were able to cross back into positive territory on early strength from the tech and healthcare sectors. Equities appear headed ...
Read Full Story »
Prescription drugs

Despite Currencies, Merck Delivers on Earnings

Merck & Co. Inc. (NYSE: MRK) has managed to beat its first-quarter earnings expectations, and handily at that. The drug giant and Dow Jones Industrial Average component reported earnings of $0.85 per ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Sank the DJIA on Monday

April 27, 2015: Markets opened higher on Monday but there was little positive news to sustain the opening gains. Biotech stocks traded lower to drag the Nasdaq Composite lower. Heavyweight ...
Read Full Story »
Pills

What to Expect From Merck and Pfizer Earnings

Pharmaceutical giants Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) are both releasing their first quarter financial results Tuesday before the markets open. Each of these companies ...
Read Full Story »
weathervane

7 DJIA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa, Chevron

Corporate earnings season now in full throttle, and 24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average components reporting their financial results in ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Weighed on the DJIA Thursday

April 16, 2015: Markets opened lower on Thursday before climbing above the break-even line in the mid-afternoon. Crude oil futures rose to another year-to-date high today and three hot IPOs ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Lifted the DJIA on Tuesday

April 14, 2015: Markets opened higher on again on Tuesday but all three major indexes slipped below the breakeven line soon thereafter. The S&P 500 and the DJIA pulled back ...
Read Full Story »
percent sign button

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

2015 is becoming a very interesting year. The bull market is now six years old, we are over three years without a true correction and the Federal Reserve is expected ...
Read Full Story »
Prescription drugs

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

While most people consider big pharmaceutical stocks very defensive, the fact of the matter is that they offer investors terrific growth and income possibilities, which can lead to outstanding total ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Boosted the DJIA on Wednesday

March 18, 2015: Markets opened lower on Wednesday and bided its time below the break-even line until just after 2 p.m. and the FOMC’s announcement that it would no longer ...
Read Full Story »
Pills

4 Top Pharmaceutical Stocks to Buy for Market Safety

Tuesday's big downward move reminded everybody that while things look encouraging for the stock market long term, momentum stocks tend to get absolutely eviscerated when a big volatility jump helps ...
Read Full Story »
Wall Street/NYSE

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

The team members at the S&P Dow Jones Indices group made a bold decision by removing AT&T Inc. (NYSE: T) from the Dow Jones Industrial Average (DJIA) and replacing it ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Weighed Down The DJIA on Monday

February 9, 2015: Markets opened lower on Monday following remarks by Greece’s new president that rattled traders. There was no U.S. economic data out today. Shortly before the closing ...
Read Full Story »
Pills

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the costs of some of the drugs on the market today. ...
Read Full Story »
Money background. Close-up.

Loss of Hep C Drug Status Weighs on Merck Earnings

Merck & Co. Inc. (NYSE: MRK) reported its fourth-quarter financial results Wednesday before the markets opened. The pharmaceutical giant had $0.87 in earnings per share (EPS) and $10.5 billion in ...
Read Full Story »